Osaic Holdings’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $2.96K | Buy |
354
+4
| +1% | +$33 | ﹤0.01% | 6374 |
|
2025
Q1 | $2.56K | Sell |
350
-67,596
| -99% | -$495K | ﹤0.01% | 6376 |
|
2024
Q4 | $580K | Buy |
67,946
+253
| +0.4% | +$2.16K | ﹤0.01% | 2653 |
|
2024
Q3 | $589K | Buy |
67,693
+42
| +0.1% | +$365 | ﹤0.01% | 2710 |
|
2024
Q2 | $463K | Buy |
67,651
+66,526
| +5,913% | +$455K | ﹤0.01% | 2837 |
|
2024
Q1 | $10.2K | Hold |
1,125
| – | – | ﹤0.01% | 5662 |
|
2023
Q4 | $5.02K | Sell |
1,125
-350
| -24% | -$1.56K | ﹤0.01% | 6098 |
|
2023
Q3 | $4.63K | Sell |
1,475
-2,537
| -63% | -$7.97K | ﹤0.01% | 6233 |
|
2023
Q2 | $20.7K | Sell |
4,012
-945
| -19% | -$4.87K | ﹤0.01% | 5517 |
|
2023
Q1 | $26.1K | Buy |
4,957
+232
| +5% | +$1.22K | ﹤0.01% | 5387 |
|
2022
Q4 | $14K | Sell |
4,725
-100
| -2% | -$296 | ﹤0.01% | 5754 |
|
2022
Q3 | $20K | Buy |
4,825
+1,100
| +30% | +$4.56K | ﹤0.01% | 5570 |
|
2022
Q2 | $15K | Hold |
3,725
| – | – | ﹤0.01% | 5799 |
|
2022
Q1 | $18K | Sell |
3,725
-11,351
| -75% | -$54.9K | ﹤0.01% | 5745 |
|
2021
Q4 | $105K | Buy |
15,076
+10,500
| +229% | +$73.1K | ﹤0.01% | 4558 |
|
2021
Q3 | $46K | Buy |
4,576
+1,200
| +36% | +$12.1K | ﹤0.01% | 5175 |
|
2021
Q2 | $48K | Buy |
3,376
+875
| +35% | +$12.4K | ﹤0.01% | 5062 |
|
2021
Q1 | $41K | Buy |
2,501
+1,900
| +316% | +$31.1K | ﹤0.01% | 4989 |
|
2020
Q4 | $12K | Sell |
601
-549
| -48% | -$11K | ﹤0.01% | 5393 |
|
2020
Q3 | $9K | Buy |
1,150
+250
| +28% | +$1.96K | ﹤0.01% | 5304 |
|
2020
Q2 | $7K | Buy |
+900
| New | +$7K | ﹤0.01% | 5285 |
|